Results 81 to 90 of about 380,384 (208)

A Case Study on Giant Malignant Phyllodes Tumor of the Breast

, 2021
Phyllodes tumor is a rare fibroepithelial tumor of the breast that account for less than 1% of all breast neoplasms [1]. Clinically, it is typically a large, smooth and fast-growing mass that forms from the periductal stroma of the breast [2].
Mariana Gomes Afonso, Ana Catarina Silva, Susana Lopes Rodrigues, Catarina Abreu Silva, Madalena Souto Moura   +4 more
core   +1 more source

Large malignant phyllodes tumor of the breast with metastases to the lungs

Rare Tumors, 2015
Phyllodes tumors of the breast account for less than 0.5% of breast cancers and present most commonly in women 45 to 49 years old. The importance in managing fibroepithelial lesions lies in distinguishing fibroadenomas, which are benign, from phyllodes ...
Alexander Augustyn, Sunati Sahoo, Rachel D. Wooldridge   +2 more
doaj   +1 more source

Role of stromal CD10 expression in classifying phyllodes tumors [PDF]

, 2019
Background: Phyllodes tumor is a rare fibroepithelial tumor of the breast comprising less than 1% of all primary breast tumor. Phyllodes tumors are classified into benign, borderline and malignant based on histological criteria.
Rajagopalan, Padmavathi, Manoharan, Hemavathi, Manoharan, Kavitha   +2 more
core   +1 more source

Review of Two Cases of Borderline Phyllodes Tumor of the Breast with Metastasis

CHRISMED Journal of Health and Research
The case series outlines two cases of borderline phyllodes tumor which later on transformed into malignant phyllodes with metastasis. Malignant phyllodes tumors, although rare, exhibit unique clinicopathological features that necessitate prompt and ...
Adil Ahmed Khan, Shivam Kumar, Zahed Ali, Dhiraj Gupta, Sanjay Sajeevan, Sweety Gupta, Deepa Joseph, Manoj Gupta   +7 more
doaj   +1 more source

Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report

BMC Surgery, 2019
Background A giant phyllodes tumor of the breast is a rare fibroepithelial lesion, and its treatment is controversial. Many case reports have reported performing skin graft reconstruction after tumor excision.
Chih-Yu Kuo, Shing-Huey Lin, Kuan-Der Lee, Sho-Jen Cheng, Jan-Show Chu, Shih-Hsin Tu   +5 more
doaj   +1 more source

Malignant phyllodes tumor of the breast presenting with hypoglycemia: a case report and literature review

, 2014
Toni Pacioles,1 Rahul Seth,2,3 Cesar Orellana,3 Ivy John,4 Veera Panuganty,3 Ruban Dhaliwal3,5 1Department of Hematology and Oncology, Edwards Comprehensive Cancer Center, Marshall University, Huntington, WV, USA; 2Division of Hematology and Oncology ...
Dhaliwal R, Orellana C, John I, Pacioles T, Panuganty V, Seth R   +5 more
core  

Comparison of Stromal CD10 Expression in Benign, Borderline and Malignant Phyllodes Tumors [PDF]

, 2015
BACKGROUND: Phyllodes tumor is a rare fibroepithelial tumor of the breast comprising less than 1% of all primary breast tumor. Phyllodes tumors are graded into benign, borderline and malignant based on histological criteria.
Hemavathi, M
core  

Imaging of Pelvic Bone Metastasis from Malignant Phyllodes Breast Tumor

, 2006
The author reports a patient with a malignant phyllodes breast tumor, who then had a ten-year disease free interval before she developed a left pelvic bone metastasis and soft tissue invasion.
Nguyen, Ba D.
core   +1 more source

EKSPRESI CD117 DAN Ki-67 PADA TUMOR PHYLLODES BENIGN, BORDERLINE DAN MALIGNANT [PDF]

, 2016
Backgroud: Phyllodes tumors are uncommon stromal-epithelial neoplasms, and classified into benign, borderline, and malignant groups on the basis of their histological features. Until now pathogenesis of phyllodes tumor is unclear.
Fetty Fatimah, NIM011181408
core   +1 more source

Integrated multi‐regional multiomic profiling of breast phyllodes tumours reveals peritumoural immune activation and stromal remodelling

Clinical and Translational Medicine
Background Breast malignant phyllodes tumours are rare fibroepithelial neoplasms arising from periductal stromal cells, characterized by rapid progression and a high recurrence rate. The poor prognosis largely stems from the lack of effective therapeutic
Tian‐Qi Gu, Lei Wang, Xiang‐Rong Wu, Qiang Zheng, Fei‐Lin Qu, Chao Chen, Gen‐Hong Di, Zhi‐Ming Shao, A‐Yong Cao   +8 more
doaj   +1 more source